Durvalumab · Ineligible · Nsclc · Promising · Radiotherapy

Durvalumab Plus Radiotherapy Promising in cCRT - Ineligible NSCLC

Covered by 1 of 114 currently active countries' press · not covered by: United Arab Emirates, Afghanistan, Algeria, Azerbaijan, Albania, Armenia, Angola, Argentina, Australia, Austria, Bahrain, Belgium…